US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Tropicamide 1%/Phenylephrine 2.5%

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3214-07 D-0290-2016
Class II · Moderate risk Terminated

Tropicamide 0.5%/ Phenylephrine 5%

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3298-02 D-0289-2016
Class II · Moderate risk Terminated

Tri-Mix 30/1/10

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3256-05 D-0288-2016
Class II · Moderate risk Terminated

Triamcinolone diacetate USP PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3206-01 D-0287-2016
Class II · Moderate risk Terminated

Triamcinolone diacetate USP

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3205-06 D-0286-2016
Class II · Moderate risk Terminated

Triamcinolone/Lidocaine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3204-07 D-0285-2016
Class II · Moderate risk Terminated

Triamcinolone acetonide

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3203-07 D-0284-2016
Class II · Moderate risk Terminated

Trace Elements-4

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3201-07 D-0283-2016
Class II · Moderate risk Terminated

Testosterone EO-Pro-Cyp 220

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-2169-06 D-0282-2016
Class II · Moderate risk Terminated

Testosterone cypionate

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-2131-07 D-0281-2016
Class II · Moderate risk Terminated

Succinylcholine Chloride

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3292-07 D-0280-2016
Class II · Moderate risk Terminated

Prednisolone Sodium Phosphate PF Solution

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc D-0279-2016
Class II · Moderate risk Terminated

Pilocarpine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc D-0278-2016
Class II · Moderate risk Terminated

Phenylephrine PF Sterile Solution

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3272-03 D-0277-2016
Class II · Moderate risk Terminated

Phenylephrine PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3159-07 D-0276-2016
Class II · Moderate risk Terminated

Phenylephrine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3289-05 D-0275-2016
Class II · Moderate risk Terminated

Phenylephrine 10% PF Ophthalmic Solution

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3273-03 D-0274-2016
Class II · Moderate risk Terminated

Phenylephrine 1.5%/ Lidocaine 1%

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3155-01 D-0273-2016
Class II · Moderate risk Terminated

Omnipaque 300

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3137-02 D-0272-2016
Class II · Moderate risk Terminated

Neostigmine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3132-05 D-0271-2016
Class II · Moderate risk Terminated

Morphine PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-2171-02 D-0270-2016
Class II · Moderate risk Terminated

MIC-Combo

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3127-06 D-0269-2016
Class II · Moderate risk Terminated

MIC Combo

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3127-06 D-0268-2016
Class II · Moderate risk Terminated

Methylprednisolone/Lidocaine

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3122-07 D-0267-2016
Class II · Moderate risk Terminated

MethylPREDNISolone PF

Reason Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

US Compounding Inc NDC 62295-3119-01 D-0266-2016